MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $20,972,000 | +258.9% | 347,789 | +173.6% | 0.07% | +266.7% |
| Q1 2016 | $5,844,000 | +55.6% | 127,108 | +63.6% | 0.02% | +63.6% |
| Q4 2015 | $3,755,000 | +14.0% | 77,673 | +0.2% | 0.01% | +10.0% |
| Q3 2015 | $3,293,000 | -85.7% | 77,488 | -61.5% | 0.01% | -83.6% |
| Q2 2015 | $22,981,000 | -38.3% | 201,232 | -30.2% | 0.06% | -35.1% |
| Q1 2015 | $37,230,000 | -9.2% | 288,450 | -29.9% | 0.09% | -9.6% |
| Q4 2014 | $40,995,000 | -34.6% | 411,559 | -35.1% | 0.10% | -33.8% |
| Q3 2014 | $62,663,000 | -69.4% | 633,795 | -76.1% | 0.16% | -32.9% |
| Q2 2014 | $204,874,000 | +75.1% | 2,657,376 | +46.2% | 0.23% | -12.0% |
| Q1 2014 | $116,998,000 | +984.6% | 1,817,579 | +975.3% | 0.27% | +1008.3% |
| Q4 2013 | $10,787,000 | -67.0% | 169,026 | -69.0% | 0.02% | -68.0% |
| Q3 2013 | $32,664,000 | +702.8% | 544,946 | +558.9% | 0.08% | +733.3% |
| Q2 2013 | $4,069,000 | – | 82,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |